Evaxion AS (EVAX)

4.45 +0.31 (+7.49%) USD  |  NASDAQ  |  Apr 17, 16:00
4.54 +0.09 (+2.02%) Pre-Market: 20:00
More

Evaxion Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Novo Nordisk A/S Upgrade
Ascendis Pharma A/S Upgrade
DBV Technologies SA --
Cellectis SA Upgrade
Akari Therapeutics Plc --